1. Continuous Low-Dose Temozolomide Chemotherapy and Microvessel Density in Recurrent Glioblastoma
   Jong-Yun Woo et al, 2015, Journal of Korean Neurosurgical Society CrossRef
2. Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma
   Heinrich Elinzano et al, 2021, American Journal of Clinical Oncology CrossRef
3. Preclinical Activity of Metronomic Regimens with Alkylating Agents and Antimetabolites
   Marta Vives et al, 2014, Metronomic Chemotherapy CrossRef
4. Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma
   Gaspar Reynés et al, 2016, Anti-Cancer Drugs CrossRef